No Data
No Data
Contrasting SPK Acquisition (NASDAQ:SPK) and Ikena Oncology (NASDAQ:IKNA)
Ikena Oncology (NASDAQ:IKNA – Get Rating) and SPK Acquisition (NASDAQ:SPK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based
SPK Acquisition Terminates Merger Agreement With Varian Biopharmaceuticals
01:52 PM EST, 12/27/2022 (MT Newswires) -- SPK Acquisition (SPK) said it terminated its merger agreement with Varian Biopharmaceuticals. SPK said in a regulatory filing it sent a notice to Varian term
SPAC SPK Scraps Merger With Varian, Will Liquidate Instead on Dec. 29
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'Certain Breaches by Varian of One or More Covenants Contained in the Merger Agreement.'
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'certain breaches by Varian of one or more covenants contained in the Merger Agreement.'
SPK Acquisition Corp. (NASDAQ:SPK) Short Interest Update
SPK Acquisition Corp. (NASDAQ:SPK – Get Rating) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,100 shares, an in
Varian Biopharmaceuticals to go public through merger with SPAC SPK Acquisition
Varian Biopharmaceuticals plans to go public through a merger with SPAC SPK Acquisition Corp (NASDAQ:SPK). The combined company's post-transaction equity value is expected to be around $116M. The dea
No Data